Our January EP Lab Digest Patient Perspective column, Stuck in the Middle: Afib Patients on Rate Control, focuses on how rate control treatment (such as beta blockers) alone impacts the quality of life of those living with atrial fibrillation. The column also explores things doctors and patients may wish to consider in determining an appropriate …
Read MoreArchives
A recent New England Journal of Medicine article reported on the results of the ARISTOTLE trial comparing the effectiveness of apixaban and warfarin for atrial fibrillation stroke prevention. Apixaban was shown to be superior to warfarin in preventing afib strokes. Learn more about the results of this trial at: Apixaban Superior to Warfarin for Atrial …
Read MoreThe US Food and Drug Administration has approved Xarelto (rivaroxaban) to reduce stroke risk in those with non-valvular atrial fibrillation (afib unrelated to heart valve problems). Xarelto is now the second oral alternative to warfarin (Coumadin) and offers an option for those unable to take warfarin or dabigatran. Xarelto is the first once-a-day alternative to …
Read MoreThe US Food & Drug Administration (FDA) Advisory Committee just voted 9-2, with 1 abstaining, to recommend that the FDA approve rivaroxaban (Xarelto) for prevention of atrial fibrillation strokes. See our full story, now up at: FDA Panel Votes for Rivaroxaban: Atrial Fibrillation Patients May Soon Have Two Alternatives to Warfarin for Stroke Prevention
Read MoreIn honor of Atrial Fibrillation (Afib) Awareness Month, Team AFib would like to invite you to our second webinar, “AFib CARE: Creating A Role for Effective Teams”, taking place at 1:00 p.m. ET on Wednesday, September 14 and hosted by StopAfib.org. To learn more, see: Join Team AFib’s Atrial Fibrillation Webinar, “AFib CARE: Creating A …
Read MoreTeam AFib is a newly-formed coalition of organizations that advocates for atrial fibrillation patients. Join Team AFib on a national tour to raise awareness about afib and its link to an increased risk for stroke. To learn more, see: Announcing Team AFib, a new coalition to advocate for atrial fibrillation patients, which includes StopAfib.org
Read MoreA study presented at the recent American College of Cardiology Scientific Sessions by Dr. Matthew Reynolds of the Harvard Clinical Research Institute showed that having a radiofrequency (RF) catheter ablation for atrial fibrillation could reduce the risk of stroke by 40% compared to those who did not have an ablation. To learn more, see: Radiofrequency …
Read MoreStopAfib.org founder Mellanie True Hills with daytime TV star Susan Lucci and her husband Helmut Huber announcing Facing AFib partnership StopAfib.org is proud to participate in the Facing AFib program, which features daytime TV star Susan Lucci and her husband Helmut Huber. More than a decade ago, Huber was diagnosed with afib. Lucci and Huber …
Read MoreDaytime TV star Susan Lucci and husband Helmut Huber discuss living with atrial fibrillation with StopAfib.org founder Mellanie True Hills in a new video released as part of the Facing AFib™ program to encourage getting serious about atrial fibrillation and stroke.
Read MoreIn late breaking clinical trials presented today at the American Heart Association Scientific Sessions, results of the ROCKET AF trial indicated that in an atrial fibrillation patient population that was at a very high risk of stroke, rivaroxaban (Xarelto) was as good as warfarin at preventing strokes. Learn more at: Rivaroxaban comparable to warfarin in …
Read More